On average, patients in clinical studies have lost 1520% of their total body weight within one year starting GLP-1 therapy, while also experiencing improvements in cholesterol, blood pressure, decreased inflammation, and higher energy levels
Its time to talk to a specialist
In a phase 2 trial, once-weekly cagrilintide produced dose-dependent weight reductions in people with overweight or obesity, which is what moved the amylin pathway into serious combination development ( Lau et al., Lancet 2021 )
But within those medications, there is an important distinction: standard-dose protocols are designed for stronger appetite suppression and more traditional weight loss titration, while microdose protocols use lower-dose strategies intended to be gentler, more gradual, and often easier to tolerate
The expiration date marks the point at which the manufacturer (or compounding pharmacy) can no longer guarantee the medication contains the labeled dose and remains free from harmful bacterial growth